MAXYGEN INC Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2007-07: Study NCT00501332; Company role Collaborator; Phase Phase 2; Status Unknown.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2007-07 | NCT00501332 Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy | Collaborator Lead: Maxygen Holdings Ltd. | Phase 2 | Unknown | Chemotherapy-Induced Neutropenia; Breast Cancer | 30 |